Raffles Associates’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Hold
87,757
0.16% 44
2026
Q1
$199K Buy
87,757
+2
+0% +$6 0.17% 45
2025
Q4
$264K Buy
87,755
+18,391
+27% +$60.1K 0.2% 49
2025
Q3
$257K Buy
69,364
+50,327
+264% +$182K 0.24% 42
2025
Q2
$75.8K Buy
+19,037
New +$85.3K 0.08% 47

Other funds holding HHS

Raffles Associates's HHS Position: Q2 2026 in Review

Raffles Associates held its Harte-Hanks (HHS) position steady in Q2 2026 at 87,757 shares worth $190K. The position accounts for 0.16% of the portfolio, ranked #44.

Raffles Associates first reported a position in HHS in Q2 2025 and has held it in 5 quarters since. The position peaked at $264K in Q4 2025. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

  • Raffles Associates held 87,757 shares of Harte-Hanks worth $190K as of Q2 2026.
  • Raffles Associates left its Harte-Hanks share count unchanged in Q2 2026.
  • Harte-Hanks made up 0.16% of Raffles Associates's portfolio in Q2 2026, its #44 holding.
  • Raffles Associates first reported a position in Harte-Hanks in Q2 2025 and has held it in 5 quarters since.
  • Raffles Associates's Harte-Hanks position peaked at $264K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on Raffles Associates's 13F filing for Q2 2026, filed 14 Aug 2026.